Kura Oncology
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-2.79-3.46-16.8074.36
Price/Sales ratio
48.074.921.361.15
Earnings per Share (EPS)
$-2.62$-2.11$-0.43$0.09

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.19-3.68-4.00-10.03-8.17-9.13-19.38-7.15-6.10-6.89-5.96-8.17
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-0.611.011.934.45-3.29-2.70-5.73-2.14-1.462.651.92-3.29
Price/Cash Flow ratio
-830.38-4.65-4.35-12.50-10.15-10.53-24.82-8.88-7.55-8.43-7.36-10.15
Price/Free Cash Flow ratio
-803.87-4.63-4.35-12.50-10.15-10.53-24.07-8.78-7.51-8.42-7.32-10.15
Price/Earnings Growth ratio
N/A0.030.11-2.94-0.620.74-1.72-0.42-1.71-2.801.99-0.62
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-2.44%0.08%0.11%0.08%-5.63%N/A0.21%0.42%-0.16%N/AN/A-5.63%
Return on Assets
-799.20%-25.92%-39.47%-36.96%-33.14%-26.09%-13.81%-24.32%-29.81%-33.99%-29.76%-33.14%
Return On Equity
320.79%-27.55%-48.45%-44.36%40.36%29.66%29.56%30.00%23.92%-38.41%-30.77%29.66%
Return on Capital Employed
720.51%-29.03%-44.06%-42.03%-37.26%-29.80%-14.82%-25.76%-32.53%-40.08%-32.35%-37.26%
Liquidity Ratios
Current Ratio
N/A17.1812.629.4313.3015.3924.48N/AN/AN/A18.5513.30
Quick Ratio
0.3917.1812.629.4313.3015.3924.4823.2518.5512.2618.2013.30
Cash ratio
0.373.051.781.131.181.6712.504.032.151.052.151.18
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
3.45K16.93K7.51K15.18K143.62KN/A5.17K2.11K737.21988.81N/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
1.83N/A0.100.070.040.030.01N/A0.020.020.070.04
Debt Equity Ratio
-0.73N/A0.120.08-0.05-0.03-0.02N/A-0.020.020.08-0.05
Long-term Debt to Capitalization
-0.16N/A0.110.06-0.05-0.03-0.01N/A-0.010.020.02-0.05
Total Debt to Capitalization
-2.79N/A0.110.08-0.05-0.03-0.02N/A-0.020.020.03-0.05
Interest Coverage Ratio
N/A-271.19-49.16-40.62-64.82-116.34-158.99N/AN/AN/A-63.23-64.82
Cash Flow to Debt Ratio
-0.00N/A-3.46-4.00-6.48-7.30-9.63N/A-9.59-11.51-7.84-7.30
Company Equity Multiplier
-0.401.061.221.20-1.21-1.13-2.13-1.23-0.801.131.08-1.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.031.0011111.031.011.001.001.001
Cash Flow Coverage Ratio
-0.00N/A-3.46-4.00-6.48-7.30-9.63N/A-9.59-11.51-7.84-7.30
Short Term Coverage Ratio
-0.00N/AN/A-18.57N/A-219.04-23.27N/A-47.48-82.88-47.48-219.04
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A